Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yanhong Feng

Showing results (61-70 of 69) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 69 results.
Medicine|August 28, 2020
Red cell distribution width to platelet ratio predicts liver fibrosis in patients with autoimmune hepatitisHuali Wang, Jian Wang, Juan Xia, et al.
Biochemical Pharmacology|January 30, 2026
MICALL2 promotes angiogenesis of colorectal cancer by regulating the EGFR/PI3K/AKT/KLF5/VEGFA axisShuzhen Hu, Fan Wang, Jiamei Xu, et al.
Journal of Clinical and Translational Hepatology|July 5, 2021
Validation of the Nanjing Criteria for Diagnosing Pyrrolizidine Alkaloids-induced Hepatic Sinusoidal Obstruction SyndromeWei Zhang, Lu Liu, Ming Zhang, et al.
International Journal of Obesity (2005)|July 4, 2026
A novel berberine derivative B12 exhibits superior anti-obesity effects via targeting brown and white adipocyte dynamicsWenqing Zhang, Yanhong Feng, Chunyi Gao, et al.
Fertility and Sterility|June 25, 2021
Circulating fibroblast growth factor 21 as a potential biomarker for missed abortion in humansYongkang Yang, Jiaming Wu, Xia Wang, et al.
Med (New York, N.Y.)|July 1, 2026
AI-driven therapeutic antisense oligonucleotide for processing-deficient progeroid laminopathiesLin Lv, Chang Liu, Lidan Hu, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of GSK2656157: An Optimized PERK Inhibitor Selected for Preclinical DevelopmentJeffrey M Axten, Stuart P Romeril, Arthur Shu, et al.
Journal of Medicinal Chemistry|July 26, 2012
Discovery of 7-methyl-5-(1-{[3-(trifluoromethyl)phenyl]acetyl}-2,3-dihydro-1H-indol-5-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine (GSK2606414), a potent and selective first-in-class inhibitor of protein kinase R (PKR)-like endoplasmic reticulum kinase (PERK)Jeffrey M Axten, Jesús R Medina, Yanhong Feng, et al.
Journal of Medicinal Chemistry|February 24, 2011
Structure-based design of potent and selective 3-phosphoinositide-dependent kinase-1 (PDK1) inhibitorsJesús R Medina, Christopher J Becker, Charles W Blackledge, et al.
Pageof 7

Showing results (61-70 of 69) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 69 results.
Medicine|August 28, 2020
Red cell distribution width to platelet ratio predicts liver fibrosis in patients with autoimmune hepatitisHuali Wang, Jian Wang, Juan Xia, et al.
Biochemical Pharmacology|January 30, 2026
MICALL2 promotes angiogenesis of colorectal cancer by regulating the EGFR/PI3K/AKT/KLF5/VEGFA axisShuzhen Hu, Fan Wang, Jiamei Xu, et al.
Journal of Clinical and Translational Hepatology|July 5, 2021
Validation of the Nanjing Criteria for Diagnosing Pyrrolizidine Alkaloids-induced Hepatic Sinusoidal Obstruction SyndromeWei Zhang, Lu Liu, Ming Zhang, et al.
International Journal of Obesity (2005)|July 4, 2026
A novel berberine derivative B12 exhibits superior anti-obesity effects via targeting brown and white adipocyte dynamicsWenqing Zhang, Yanhong Feng, Chunyi Gao, et al.
Fertility and Sterility|June 25, 2021
Circulating fibroblast growth factor 21 as a potential biomarker for missed abortion in humansYongkang Yang, Jiaming Wu, Xia Wang, et al.
Med (New York, N.Y.)|July 1, 2026
AI-driven therapeutic antisense oligonucleotide for processing-deficient progeroid laminopathiesLin Lv, Chang Liu, Lidan Hu, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of GSK2656157: An Optimized PERK Inhibitor Selected for Preclinical DevelopmentJeffrey M Axten, Stuart P Romeril, Arthur Shu, et al.
Journal of Medicinal Chemistry|July 26, 2012
Discovery of 7-methyl-5-(1-{[3-(trifluoromethyl)phenyl]acetyl}-2,3-dihydro-1H-indol-5-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine (GSK2606414), a potent and selective first-in-class inhibitor of protein kinase R (PKR)-like endoplasmic reticulum kinase (PERK)Jeffrey M Axten, Jesús R Medina, Yanhong Feng, et al.
Journal of Medicinal Chemistry|February 24, 2011
Structure-based design of potent and selective 3-phosphoinositide-dependent kinase-1 (PDK1) inhibitorsJesús R Medina, Christopher J Becker, Charles W Blackledge, et al.
Pageof 7